America Stem Cell, Inc. Receives FDA Clearance for Its Multi-Center Nationwide Trial

America Stem Cell, Inc. announced today it has received clearance from FDA for its Phase I/IIa nationwide multi-center dual-umbilical cord transplantation study evaluating ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

http://www.businesswire.com/news/topix/20130905005368/en